ETF Holdings Breakdown of TXG

Stock Name	10X Genomics Inc
Ticker	TXG(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US88025U1097
LEI	5493003Z6741WNLG7H43
Ticker	TXG(EUR) F

TXG institutional holdings

The following institutional investment holdings of TXG have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2026-01-15 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 720 USD 15,264 1.3% 21.20

2026-01-15 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 22,796 15.3% USD 483,275 16.4% 21.20

2026-01-15 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 79,851 0.5% USD 1,692,841 1.8% 21.20

2026-01-15 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 76,848 USD 1,629,178 1.3% 21.20

2026-01-15 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 79,851 0.5% USD 1,692,841 1.8% 21.20

2026-01-15 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 138,018 USD 2,925,982 1.3% 21.20

Total = 398,084 USD 8,439,381
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2026-01-15	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	720	USD 15,264 1.3%	21.20
2026-01-15	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	22,796 15.3%	USD 483,275 16.4%	21.20
2026-01-15	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	79,851 0.5%	USD 1,692,841 1.8%	21.20
2026-01-15	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	76,848	USD 1,629,178 1.3%	21.20
2026-01-15	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	79,851 0.5%	USD 1,692,841 1.8%	21.20
2026-01-15	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	138,018	USD 2,925,982 1.3%	21.20
Total =	398,084	USD 8,439,381

News associated with TXG

TXG Crosses Above Average Analyst Target: In recent trading, shares of 10x Genomics Inc (Symbol: TXG) have crossed above the average analyst 12-month target price of $13.25, changing hands for $13.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valu - 2025-08-05 07:41:55

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.